<SEC-DOCUMENT>0001610618-23-000083-index.html : 20230814
<SEC-HEADER>0001610618-23-000083.hdr.sgml : 20230814
<ACCEPTANCE-DATETIME>20230814194018
ACCESSION NUMBER:		0001610618-23-000083
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20230814
FILED AS OF DATE:		20230814
DATE AS OF CHANGE:		20230814

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Tari Leslie
		CENTRAL INDEX KEY:			0001870270

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36912
		FILM NUMBER:		231172829

	MAIL ADDRESS:	
		STREET 1:		C/O CIDARA THERAPEUTICS, INC.
		STREET 2:		6310 NANCY RIDGE DR SUITE 101
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cidara Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001610618
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				461537286
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		6310 NANCY RIDGE DRIVE
		STREET 2:		SUITE 101
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-752-6170

	MAIL ADDRESS:	
		STREET 1:		6310 NANCY RIDGE DRIVE
		STREET 2:		SUITE 101
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	K2 THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20140611
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>wf-form4_169205640011946.xml
<DESCRIPTION>FORM 4
<TEXT>
Document 1 - file: wf-form4_169205640011946.html

Document 1 - RAW XML: wf-form4_169205640011946.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>a2022cidara-section16poale.htm
<DESCRIPTION>POWER OF ATTORNEY, TARI
<TEXT>
Document 2 - file: a2022cidara-section16poale.htm

</DOCUMENT>
</SEC-DOCUMENT>